Argonaute RNA

Private

CardiffHealthcare & Life Scienceshttps://argonauterna.com/

Last Round

Seed

Jul 17, 2024

Total Funding Raised

$4.25M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Argonaute RNA is a biotechnology company that develops bispecific small interfering RNA (siRNA) therapeutics to silence specific genes for the treatment of cardiometabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

RNA interferenceRNAisiRNA therapeuticsgene silencingbispecific siRNAdrug discoverycardiometabolic diseaseDNA nanotechnologybiotechtherapeutic pipelineoligonucleotide therapybiotech licensingRNA medicinegene therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Argonaute RNA Comps

Public and private peers based on sector, stage, and business model.

Argonaute RNA comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Argonaute RNA Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 17, 2024
Seed	May 26, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Michael Khan

Chief Executive Officer

Executive Team

Argonaute RNA Investors

Notable investors and investment history

Argonaute RNA investors
Investor	Rounds
Bristol Private Equity Club	Seed
Fink Family Office	Seed
Empirical Ventures	Seed
Development Bank of Wales	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 17, 2026
Monthly visitors increased 57% MoM.

View all signals

Argonaute RNA Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Argonaute RNA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Argonaute RNA's valuation, stock price, and market status.

Firmographic Details

HeadquartersCardiff

Employee Range13

Year Founded2015

Last FundingJul 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.